Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Boost for drugs against hepatitis C

Promising clinical trial results point to the pharmaceutical industry's next blockbuster.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Authors

Related links

Related links

Related links in Nature Research

Nature Reviews Drug Discovery: Hepatitis C treatment

Related external links

Paul Klenerman

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callaway, E. Boost for drugs against hepatitis C. Nature (2010). https://doi.org/10.1038/news.2010.408

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.408

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research